Home › Funds › Point72 Asset Management › GPCR
Point72 Asset Management position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Latest position (Q3 2025)407.70K sh
Reported value held$11.42M
Portfolio Weight0.02%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 349.86K | $8.32M | New |
| Q2 2023 | 431.00K | $17.92M | Add |
| Q3 2023 | 747.10K | $37.67M | Add |
| Q2 2024 | 417.68K | $16.40M | New |
| Q3 2024 | 1.24M | $54.35M | Add |
| Q4 2024 | 626.70K | $17.00M | Reduce |
| Q1 2025 | 229.43K | $3.97M | Reduce |
| Q2 2025 | 330.00K | $6.84M | Add |
| Q3 2025 | 407.70K | $11.42M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GPCR
- Fidelity Management & Research (FMR) 7.81M sh · $419.18M · Q2 2026
- Wellington Management Group 7.38M sh · $396.05M · Q2 2026
- Morgan Stanley 2.81M sh · $150.63M · Q2 2026
- Principal Global Investors 1.75M sh · $94.07M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- Franklin Resources 578.84K sh · $31.07M · Q2 2026
- Bank of America Corp 563.42K sh · $30.24M · Q2 2026
- BlackRock Inc 511.15K sh · $27.43M · Q2 2026
- Goldman Sachs Group 387.79K sh · $20.81M · Q2 2026
- UBS Group AG 378.99K sh · $20.34M · Q2 2026
- Deutsche Bank AG 331.87K sh · $17.81M · Q2 2026
- Marshall Wace 267.59K sh · $14.36M · Q2 2026